DeepMed Research

CENTRE HOSPITALIER UNIVERSITAIRE DE DIJON

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.chu-dijon.fr

Clinical Trials

Study of the Impact of HYPOglycaemia on Sarcopenia in CIRrhosis

Not yet recruiting

Conditions: Cirrhosis

First Posted Date: 2025-04-29

Last Posted Date: 2025-04-29

Lead Sponsor: Centre Hospitalier Universitaire Dijon

Target Recruit Count: 200

Registration Number: NCT06948656

Locations: 🇫🇷
CHU Dijon Bourgogne, Dijon, France

POlycythemia, Proteins and ErYthropoiesis

Recruiting

Conditions: Erythropoiesis

Interventions: Biological: Collection of tube bottoms from blood samples taken in the clinic

First Posted Date: 2025-04-01

Last Posted Date: 2025-04-01

Lead Sponsor: Centre Hospitalier Universitaire Dijon

Target Recruit Count: 400

Registration Number: NCT06905106

Locations: 🇫🇷
CHU Dijon Bourgogne, Dijon, France

A Pilot Study to Assess the Feasibility and Acceptability of Newborn Screening Using in Silico Panel-based Solo Genome Sequencing in France

Recruiting

Conditions: Newborn Screening Programmes for Rare Diseases

First Posted Date: 2025-03-13

Last Posted Date: 2025-05-14

Lead Sponsor: Centre Hospitalier Universitaire Dijon

Target Recruit Count: 5000

Registration Number: NCT06875089

Locations: 🇫🇷
CHU d'Angers, Angers, France
🇫🇷
CHU Dijon Bourgogne, Dijon, France
🇫🇷
CHU Hôtel Dieu, Nantes, France

and more 2 locations

PRODIGE 98 : Randomized, Multicenter Phase 3 Trial of Adjuvant Chemotherapy with Modified FOLFIRINOX Versus Capecitabine or Gemcitabine in Patients with Resected Ampullary Adenocarcinoma

Phase 3

Not yet recruiting

Conditions: Ampullary Adenocarcinoma

Interventions: Drug: mFOLFORINOX
Drug: Capecitabine or gemcitabine
Biological: Biological assessment
Diagnostic Test: Paraclinical examinations

First Posted Date: 2025-02-07

Last Posted Date: 2025-02-07

Lead Sponsor: Centre Hospitalier Universitaire Dijon

Target Recruit Count: 294

Registration Number: NCT06813976

Locations: 🇫🇷
CHU Dijon Bourgogne, Dijon, France

A Placebo-controlled Evaluation of Low Dose Lithium Carbonate in Patients with TBR1-related Neurocognitive Disorders

Phase 1

Not yet recruiting

Conditions: Proven Pathogenic or Probably Pathogenic TBR1 Variant

Interventions: Other: Observation phase
Drug: Lithium treatment
Biological: biological monitoring

First Posted Date: 2025-01-15

Last Posted Date: 2025-01-15

Lead Sponsor: Centre Hospitalier Universitaire Dijon

Target Recruit Count: 12

Registration Number: NCT06776848

Locations: 🇫🇷
CHU Dijon Bourgogne, Dijon, France

Aspirin in Acute Pneumonia in the Elderly: a Multicenter, Double-blind, Randomized, Placebo-controlled Trial.

Phase 3

Not yet recruiting

Conditions: Elderly Person
Acute Pneumonia

Interventions: Drug: Acetylsalicylic acid/Aspirin (100 mg)
Drug: Placebo acetylsalicylic acid (100 mg) / 0.9% sodium chloride

First Posted Date: 2025-01-14

Last Posted Date: 2025-01-14

Lead Sponsor: Centre Hospitalier Universitaire Dijon

Target Recruit Count: 600

Registration Number: NCT06774846

PRODIGE 90 - (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch-and-wait Strategy for Microsatellite Unstable or Mismatch Repair-deficient Locally Advanced Rectal Cancer Patients

Phase 3

Recruiting

Conditions: Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)

Interventions: Radiation: radiotherapy
Drug: Dostarlimab
Biological: Biological study on circulating tumor DNA (optional for the patient)

First Posted Date: 2025-01-07

Last Posted Date: 2025-02-18

Lead Sponsor: Centre Hospitalier Universitaire Dijon

Target Recruit Count: 68

Registration Number: NCT06762405

Locations: 🇫🇷
CHU Dijon Bourgogne, Dijon, France

Choice of Anticoagulant for Primary Hemostasis Studies with PFA200® (Platelet Function Analyser)

Recruiting

Conditions: Hemostasis

Interventions: Biological: Sampling of 3 additional BAPA tubes

First Posted Date: 2024-12-31

Last Posted Date: 2025-01-22

Lead Sponsor: Centre Hospitalier Universitaire Dijon

Target Recruit Count: 100

Registration Number: NCT06753838

Locations: 🇫🇷
CHU Dijon Bourgogne, Dijon, France

Implementation of a Tumor Response Assessment Program Integrating the Shared Medical Decision Into the Organ Preservation Strategy for Rectal Cancer Patients

Not Applicable

Recruiting

Conditions: Rectal Cancer

First Posted Date: 2024-12-18

Last Posted Date: 2025-04-09

Lead Sponsor: Centre Hospitalier Universitaire Dijon

Target Recruit Count: 270

Registration Number: NCT06740357

Locations: 🇫🇷
CHU Dijon Bourgogne, Dijon, France

SOcioeconomics Status and Post-Intensive Care Syndrome

Not yet recruiting

Conditions: Post Intensive Care Syndrome (PICS)

First Posted Date: 2024-11-20

Last Posted Date: 2024-11-20

Lead Sponsor: Centre Hospitalier Universitaire Dijon

Target Recruit Count: 180

Registration Number: NCT06697236

Locations: 🇫🇷
CHU Dijon Bourgogne, Dijon, France

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy